Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VASE: Sirolimus in Refractory Vascular Anomalies
NCT02638389Phase 3Recruiting
- Start
- Jan 2016
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of sirolimus in vascular malformations (VM). Started Jan 2016; status: recruiting.
02
Drugs
sirolimus
03
Conditions
vascular malformations (VM)
Beyond the preview
Go deeper on NCT02638389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638389.